tislelizumab,dkn-01
beigene,novartis,leap therapeutics
['distinguish trial']
proud to have contributed to the distinguish trial promising results presented at asco by 
Medical Director, GI Oncology Program - AdventHealth Cancer Institute. Passionate about clinical research, education and pt-prov communication. #gicancer #meded